The evidence supporting causality includes HERV-W env overexpression preceding multiple sclerosis symptoms (Kury et al., 2018) and HERV-K-driven oncogene activation in early tumorigenesis (Mao et al., 2021). This evidence concerns the gene ERVW-1 and multiple sclerosis.